Kanjinti (biosimilar Herceptin drug)
Hi All,
My mother has just been informed that all patients currently on Herceptin will be switched to this new biosimilar drug, Kanjinti. It was recently FDA approved for HER2 positive patients on Herecptin. Kaiser has adopted it and will switch all patients (including breast cancer) to this new drug. I'm unfamiliar with "biosimilar" drugs but my superficial research says it is nearly identical in efficacy and side effects, and does in fact contain the same ingredient - trastuzumab. Does anyone have knowledge or experience with this drug?
Keeping you all in my thoughts as we forge on. New drugs and advances all the time.
Thanks everyone,
Jenny
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 396 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.3K Kidney Cancer
- 670 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 537 Sarcoma
- 730 Skin Cancer
- 652 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards